After initial hiccup, many private hospitals start offering COVID-19 vaccine booster doses; demand rises on day 2
- health
- April 12, 2022
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
कोरोना वायरस के खिलाफ देश में बने टीके ‘कोवैक्सिन ‘का सोमवार को भुवनेश्वर के इंस्टीट्यूट ऑफ मेडिकल साइंसेस एंड एसयूएम अस्पताल में मानव परीक्षण शुरू हो गया है. Covaxin टीके को भारत बायोटेक ने विकसित किया है. ह्यूमन ट्रायल (मानव परीक्षण) के प्रधान जांचकर्ता डॉक्टर ई वेंकट राव ने कहा कि Covaxin टीका कुछ लोगों
READ MOREThe relationship between India and China is complex, often marked by both cooperation and competition. This complexity extends to the realm of visas, with recent developments indicating a potential shift. India is reportedly considering reforms to expedite visa processing for Chinese technicians, a move aimed at bolstering its manufacturing ambitions. The Business Case for Change
READ MOREOn July 11th, 2024, a significant milestone was achieved for India’s maritime industry. The Adani Group’s Vizhinjam port near Kovalam Beach in Kerala welcomed its inaugural mothership, the MV San Fernando. This momentous occasion marks the arrival of a new era for cargo handling in India, placing the country on the global trans-shipment map. What
READ MORETCS Q1 results presented a mixed picture. On the one hand, the company achieved revenue growth in line with analyst expectations. This indicates that TCS is successfully navigating a challenging global economic environment and securing new business opportunities. On the other hand, there was a slight dip in profit margins. This could be due to
READ MORE